Costs and management of patients with hemophilia A in France: the Hemraude study.
LAURENDEAU C, GOUDEMAND J, TROSSAERT M, POLACK B, VARIN R, GODARD C, HADIM F, DETOURNAY B.
Eur J Health Econ. ; 2022;23(1):23-32
Économie de la santé
Cost-effectiveness of emicizumab vs bypassing agents in the prevention of bleeding episodes in haemophilia A patients with anti-FVIII inhibitors in France.
POLACK B, TROSSAËRT M, COUSIN M, BAFFERT S, PRUVOT A, GODARD C.
Haemophilia ; 2020;27(1)e1-e11
Biométrie et Analyses de bases de données
Anemia Management Practice in French Hemodialysis Centers.
ROTTEMBOURG J, URENA TORRES P, LE MONIES DE SAGAZAN H, SIRAJEDINE K, EMERY C, ZAKIN L, WERNLI J, MAHI L.
Br J Med Med Res ; 2015;5(11):1338-1348
Pharmaco-Epidémiologie
Do two intravenous iron sucrose preparations have the same efficacy?
ROTTEMBOURG J, KADRI A, LEONARD E, DANSAERT A, LAFUMA A
Nephrol Dial Transplant ; 2011;26(10):3262-3267
Pharmaco-Epidémiologie
Do two intravenous iron sucrose preparations have the same efficacy ?
ROTTEMBOURG J, KADRI A, LEONARD E, DANSAERT A, LAFUMA A
Règlement général sur la protection des données
